Ireland - English - HPRA (Health Products Regulatory Authority)

acs dobfar s.p.a. - meropenem - powder for solution for injection/infusion - meropenem

Ireland - English - HPRA (Health Products Regulatory Authority)

acs dobfar s.p.a. - meropenem - powder for solution for injection/infusion - meropenem

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - meropenem trihydrate - powder for solution for injection/infusion - meropenem

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - meropenem trihydrate - powder for solution for injection/infusion - meropenem

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 20 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - meropenem trihydrate - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - meropenem trihydrate - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem

United States - English - NLM (National Library of Medicine)

cardinal health - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 10 ml

United States - English - NLM (National Library of Medicine)

hospira, inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp (i.v.) is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp (i.v.) has been found to be

United States - English - NLM (National Library of Medicine)

wg critical care, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp has been found to be effective in eliminating con